SCHEMBL1720658

SCHEMBL1720658

CCCCCCCC/C=C\CCCCCCCC(=O)OC(C)CC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.59
PRKCE Q02156 1/20 0.59
PRKCQ Q04759 1/20 0.59
PRKCD Q05655 1/20 0.59
LMNA P02545 3/20 0.59
FAAH O00519 3/20 0.56
MAPT P10636 3/20 0.56
ALDH1A1 P00352 1/20 0.56
HPGD P15428 1/20 0.56
CNR1 P21554 1/20 0.56
CNR2 P34972 1/20 0.56
DGKA P23743 1/20 0.55
TERT O14746 3/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
PTPN1 P18031 2/20 0.54
PPARG P37231 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28814217 1.00 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL1720660 1.00 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL28580959 0.97 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL29521415 0.97 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL28581640 0.97 PRKCA (0.56) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL27982736 0.95 ALDH1A1 (0.63) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL27982735 0.91 ALDH1A1 (0.69) LMNAFAAHMAPTALDH1A1HPGD
SCHEMBL27982737 0.91 ALDH1A1 (0.69) LMNAFAAHMAPTALDH1A1HPGD
SCHEMBL12614545 0.90 ALDH1A1 (0.56) PRKCAPRKCEPRKCQPRKCDLMNA
SCHEMBL12614543 0.90 ALDH1A1 (0.56) PRKCAPRKCEPRKCQPRKCDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119970641-A Nonaqueous preparation with controllable release behavior and application thereof 中国科学院上海药物研究所 2025-05-13 CN claimed
EP-3065732-B1 COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA CENTRE NAT RECH SCIENT (FR) 2018-04-11 EP claimed
US-9821000-B2 Compounds, compositions and corresponding uses for preventing and/or treating of dyslipidemia CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2017-11-21 US claimed
US-20160287542-A1 COMPOUNDS, COMPOSITIONS AND CORRESPONDING USES FOR PREVENTING AND/OR TREATING OF DYSLIPIDEMIA UNIVERSITE DE POITIERS (FR) 2016-10-06 US claimed
EP-3065732-A1 COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA Centre National de la Recherche Scientifique (CNRS) (FR) 2016-09-14 EP claimed
WO-2015052237-A1 COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2015-04-16 WO claimed
US-20260144731-A1 AQUEOUS GEL, COSMETIC USE THEREOF AND PROCESS FOR REDUCING THE TACKINESS FELT DURING ITS APPLICATION SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2026-05-28 US disclosed
CN-122075314-A Aqueous gel, cosmetic use thereof and method for reducing the sticky feel during the application thereof 2026-05-26 CN disclosed
US-12551415-B2 Cosmetic composition in the form of a water-in-oil emulsion for treating hair to improve combing SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2026-02-17 US disclosed
EP-4683608-A1 PROCESS FOR THE PREPARATION OF A POLAR LIPID-ENRICHED ALGAL EXTRACT Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2026-01-28 EP disclosed
EP-4683609-A1 HIMANTHALIA ELONGATA EXTRACT, COSMETIC COMPOSITION COMPRISING SAME, AND USES THEREOF Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2026-01-28 EP disclosed
US-12478575-B2 Stable perfuming compositions having good spray properties SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES—SEPPIC (FR) 2025-11-25 US disclosed
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-10-16 US disclosed
EP-2406357-B1 PROCESS FOR PRODUCING MODIFIED VEGETABLE OIL LUBRICANTS BATTELLE MEMORIAL INSTITUTE (US) 2016-04-27 EP disclosed
WO-2015052237-A1 COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND/OR TREATMENT OF DYSLIPIDEMIA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2015-04-16 WO disclosed
EP-2799528-A1 Modified vegetable oil lubricants BATTELLE MEMORIAL INSTITUTE (US) 2014-11-05 EP disclosed
US-20120129746-A1 MODIFIED VEGETABLE OIL LUBRICANTS BATELLE MEMORIAL INSTITUTE (US) 2012-05-24 US disclosed
EP-2406357-A2 MODIFIED VEGETABLE OIL LUBRICANTS Battelle Memorial Institute (US) 2012-01-18 EP disclosed
WO-2010104609-A2 MODIFIED VEGETABLE OIL LUBRICANTS BATTELLE MEMORIAL INSTITUTE (US) 2010-09-16 WO disclosed
US-5030521-A Magnetic recording medium using a fatty acid ester lubricant wherein the alcohol component is branched at the number one carbon position FUJI PHOTO FILM CO., LTD. (JP) 1991-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12478575-B2 Stable perfuming compositions having good spray properties PARG, PLG, POLG PRKCA 1577/4885PRKCE 1209/4885PRKCQ 392/4885
US-20260144731-A1 AQUEOUS GEL, COSMETIC USE THEREOF AND PROCESS FOR REDUCING THE TACKINESS FELT DURING ITS APPLICATION OGG1, CUTA, ACP1 PRKCA 1909/4885PRKCE 1806/4885PRKCQ 2221/4885
US-20160287542-A1 COMPOUNDS, COMPOSITIONS AND CORRESPONDING USES FOR PREVENTING AND/OR TREATING OF DYSLIPIDEMIA LIPC, CPT1A, LIPA PRKCA 1279/4885PRKCE 1347/4885PRKCQ 1822/4885
US-20120129746-A1 MODIFIED VEGETABLE OIL LUBRICANTS DAGLA, MGLL, FYN PRKCA 374/4885PRKCE 271/4885PRKCQ 1013/4885
US-12551415-B2 Cosmetic composition in the form of a water-in-oil emulsion for treating hair to improve combing PHOSPHO1, LIPC, ACOT7 PRKCA 549/4885PRKCE 465/4885PRKCQ 418/4885
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS PHOSPHO1, ELOVL5, PARG PRKCA 555/4885PRKCE 280/4885PRKCQ 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.